Dopamine is a novel, direct inducer of catagen in human scalp hair folliclesin vitro
December 2012
in “British Journal of Dermatology”
TLDR Dopamine stops hair growth and pigment production in human scalp hair follicles.
The study from 2012 investigated the effects of dopamine on human scalp hair follicles in vitro, specifically looking at hair growth, pigmentation, and dopamine receptor expression. Treating microdissected human scalp hair follicles from women with dopamine led to a significant induction of catagen phase (hair follicle regression), a decrease in keratinocyte proliferation (P < 0.01), and reduced melanin production within the follicles. Dopamine receptor transcripts were found in both hair follicles and skin. The study, which included groups of 9-39 hair follicles from women aged 47-68, concluded that dopamine acts as an inhibitor of hair growth and could potentially be used to treat unwanted hair growth, while suggesting that dopamine receptor antagonists might promote hair growth. Further research is needed to confirm these findings in a larger sample size and in vivo.
View this study on dea.lib.unideb.hu →
Cited in this study
research Mind the (Gender) Gap: Does Prolactin Exert Gender and/or Site-Specific Effects on the Human Hair Follicle?
Prolactin may affect hair growth differently based on gender and scalp area.
research Prolactin—a novel neuroendocrine regulator of human keratin expressionin situ
Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.
research Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease
A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.
research Alopecia Due to Psychotropic Medications
Some psychotropic medications can rarely cause hair loss, and stopping these drugs usually reverses the condition.